CFP anticorps (Middle Region)
Aperçu rapide pour CFP anticorps (Middle Region) (ABIN954312)
Antigène
Voir toutes CFP AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 203-233, Middle Region
-
Specificité
- This antibody reaccts to CFP.
-
Réactivité croisée (Details)
- Species reactivity (tested):Human.
-
Purification
- Affinity chromatography on Protein A
-
Immunogène
- KLH conjugated synthetic peptide between 203~233 amino acids from the Central region of human CFP
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS, 0.09 % (W/V) sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- CFP (Complement Factor P (CFP))
-
Autre désignation
- Properdin
-
Sujet
- This gene encodes a plasma glycoprotein that positively regulates the alternative complement pathway of the innate immune system. This protein binds to many microbial surfaces and apoptotic cells and stabilizes the C3- and C5-convertase enzyme complexes in a feedback loop that ultimately leads to formation of the membrane attack complex and lysis of the target cell. Mutations in this gene result in two forms of properdin deficiency, which results in high susceptibility to meningococcal infections.Synonyms: CFP, Complement factor P, PFC
-
Poids moléculaire
- 51276 Da
-
ID gène
- 5199
-
NCBI Accession
- NP_001138724
-
Pathways
- Système du Complément
Antigène
-